The Global Genetic Testing Market Size accounted for USD 14.1 Billion in 2022 and is estimated to achieve a market size of USD 36.7 Billion by 2032 growing at a CAGR of 10.3% from 2023 to 2032.
Genetic Testing Market Highlights
- Global genetic testing market revenue is poised to garner USD 36.7 billion by 2032 with a CAGR of 10.3% from 2023 to 2032
- North America genetic testing market value occupied around USD 7.8 billion in 2022
- Asia-Pacific genetic testing market growth will record a CAGR of more than 12% from 2023 to 2032
- Among type, the diagnostic testing sub-segment generated over US$ 7.2 billion revenue in 2022
- Based on technology, the molecular testing sub-segment generated around 56% share in 2022
- Penetration into emerging markets is a popular genetic testing market trend that fuels the industry demand
Genetic testing involves studying genes within cells and tissues, aiding in the understanding of various genetic disorders such as cancer, sickle cell anemia, cystic fibrosis, Down syndrome, and more. This examination explores the application of genetic tests in developing individualized medicine and treating conditions like cancer. It highlights diverse techniques like genomic hybridization, fluorescence in situ hybridization, karyotyping, and others for detecting genetic abnormalities and cancers. These methods encompass cytogenetic testing, chromosome analysis, biochemical trials, molecular testing, and DNA sequencing. They utilize products such as kits, media, reagents, and other essentials for genetic testing.
Global Genetic Testing Market Dynamics
Market Drivers
- Advancements in genomic technology
- Rising prevalence of genetic disorders
- Growing awareness and adoption of personalized medicine
- Expanded applications in oncology
Market Restraints
- Ethical and privacy concerns
- High costs associated with testing
- Privacy concerns regarding genetic data create reluctance among individuals
Market Opportunities
- Expanding applications in oncology and pharmacogenomics
- Rising demand for non-invasive prenatal testing
- Integration of AI and machine learning
Genetic Testing Market Report Coverage
| Market |
Genetic Testing Market
|
| Genetic Testing Market Size 2022 |
USD 14.1 Billion |
| Genetic Testing Market Forecast 2032 |
USD 36.7 Billion |
| Genetic Testing Market CAGR During 2023 - 2032 |
10.3% |
| Genetic Testing Market Analysis Period |
2020 - 2032 |
Genetic Testing Market Base Year
|
2022 |
| Genetic Testing Market Forecast Data |
2023 - 2032 |
| Segments Covered |
By Type, By Product, By Technology, By Application, By End-user, And By Geography
|
| Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Key Companies Profiled |
23andMe, Abbott Molecular, Biocartis, BioHelix, Bayer Diagnostics, BioMerieux, BGI, Celera Genomics, Cepheid, Counsyl, deCODEme, Genentech, Genomictree, HTG Molecular Diagnostics, Luminex, MolecularMD, IntegraGen, LabCorp diagnostics, Myriad, Natera, PacBio, Pathway Genomics, Qiagen, and Roche Diagnostic
|
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Covid-19 Analysis, Regulation Analysis |
Genetic Testing Market Insights
In the near future, the global genetic testing market is poised for substantial growth due to the increasing prevalence of genetic disorders, cancerous diseases, and the rising acceptance of personalized medicinal products. Advancements in genetic testing techniques, particularly in genetic oncology testing, will significantly propel market expansion in the forecasted period. However, concerns regarding standardization in genetic testing-based diagnoses and stringent regulatory approvals might pose obstacles to market growth. Conversely, untapped emerging markets in developing countries present lucrative opportunities for market players. These factors are expected to contribute to an increased global market share for genetic testing.
The genetic testing market is experiencing substantial growth due to increasing awareness and investments in this field. Genetic testing involves analyzing human DNA, RNA, chromosomes, or related products, aiding in the detection of genotype, phenotype, or mutation-related diseases. These tests are utilized for clinical purposes, including the detection of karyotype abnormalities.
Genetic testing offers several advantages, notably the early detection of genetic abnormalities at around 8 to 10 weeks of gestation and the ability to determine the fetus's sex. Consequently, the popularity of genetic testing is on the rise, driven by increased awareness and advancements in the field. Among various genetic tests, screening for genetic mutations in the Cystic Fibrosis gene's trans-membrane conductance regulator gene (CFTR) stands as the most common procedure in genetic testing.
Genetic Testing Market Segmentation
The worldwide market for genetic testing is split based on type, product, technology, application, end-user, and geography.
Genetic Testing Types
- Predictive Testing
- Prenatal & Newborn Testing
- Diagnostic Testing
- Carrier Testing
- Pharmacogenomic Testing
- Others
According to genetic testing industry analysis, the market segments into prenatal, newborn, diagnostic tests, pharmacogenomic tests, and others based on type. Presently, the diagnostic test segment leads the market in 2022, and its dominance is forecasted to persist. This dominance stems from heightened human health awareness and increased mortality rates globally due to genetic diseases. Conversely, during the genetic testing indystry forecast period, the pharmacogenomic test segment is expected to exhibit the most effective compound annual growth rate. This trend is primarily driven by pharmaceutical companies increasingly leveraging these tests in drug discovery and development processes.
Genetic Testing Products
- Consumables
- Equipment
- Software & Services
The consumables segment dominates the genetic testing market due to its critical role in the execution of numerous tests. Consumables include reagents, testing kits, and sample collection tools that are required for genetic analysis. Their importance stems from their capacity to provide precise and quick testing processes while also providing reliability and consistency in outcomes. As the demand for genetic testing grows in the healthcare, research, and pharmaceutical sectors, the consumables segment maintains its prominence by providing the essential materials required for comprehensive and precise genetic analyses, highlighting its market dominance.
Genetic Testing Technologies
- Biochemical Testing
- Cytogenetic Testing/ Chromosome Analysis
- Molecular Testing
As per the genetic testing market analysis, the molecular testing sector leads the industry due to its precision and adaptability in examining DNA, RNA, and genes at the molecular level. Molecular testing, which employs procedures such as PCR, DNA sequencing, and hybridization, allows for a thorough evaluation of genetic variants, mutations, and disease risks. Its capacity to quickly offer very specific and accurate results has driven it to prominence. The versatility of this market across many applications, such as oncology, infectious illnesses, and pharmacogenomics, drives its expansion. As personalised medicine gains pace, molecular testing continues to play an important role in driving improvements and expanding possibilities in understanding genetic intricacies and diseases with unprecedented depth and precision.
Genetic Testing Applications
- Ancestry & Ethnicity
- Traits Screening
- Genetic Disease Carrier Status
- New Baby Screening
- Health and Wellness-Predisposition/Risk/Tendency
The health and wellness-predisposition/risk/tendency category controls the majority of the genetic testing market due to its numerous applications in personalised healthcare. This part provides information into an individual's susceptibility to certain health issues, supporting proactive health management. It enables early intervention and lifestyle changes by analysing genetic risks for diseases such as diabetes, cardiovascular disease, and cancer. It also provides information about pharmaceutical reactions and susceptibility to specific illnesses, allowing for more personalised healthcare plans. With increased public interest in preventative health measures, this segment's emphasis on personalised risk assessment and wellness solutions solidifies its leadership position in the genetic testing environment.
Genetic Testing End-Users
- Hospitals & Clinics
- Diagnostic Laboratories
- Others
Hospitals and clinics account for the majority of the genetic testing market due to their vital role in healthcare delivery. These are the key points of contact for patients, and genetic tests are frequently performed for a variety of purposes, including disease diagnosis, risk assessment, and personalised therapy planning. Hospitals and clinics are the favoured choice for genetic testing due to their accessibility, comprehensive facilities, and integration with healthcare services. Furthermore, the presence of qualified medical experts in these locations ensures proper testing, result interpretation, and appropriate patient counselling, further cementing their supremacy in this sector.
Genetic Testing Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Genetic Testing Market Regional Analysis
The industry, which registered sales of US$ 7.8 billion in North America in 2022, is poised for substantial growth in the genetic testing market forecast period. This growth is attributed to the increasing incidence of genetic disorders such as cancer, Turner syndrome, neurofibromatosis, and spinal muscle atrophy. The introduction of new tests, driven by technological advancements, is expected to fuel the demand for genetic testing. Over the coming years, market expansion will be bolstered by advanced infrastructure, robust healthcare systems, and regulatory support, especially for direct-to-consumer genetic testing.
Asia-Pacific genetic test market is projected to witness a robust Compound Annual Growth Rate (CAGR) of around 12%, primarily due to the rising prevalence of various cancers like prostate, breast, and lung cancer. Breast cancer, notably the most prevalent cancer among females in Asia-Pacific, is estimated to increase largest by 2030 according to the Pan American Health Organization (PAHO), with approximately 4,08,200 affected women. The accelerating regional growth will be driven by genetic tests facilitating early detection and prevention of cancer and other genetic conditions.
Genetic Testing Market Players
Some of the top genetic testing companies offered in our report includes 23andMe, Abbott Molecular, Biocartis, BioHelix, Bayer Diagnostics, BioMerieux, BGI, Celera Genomics, Cepheid, Counsyl, deCODEme, Genentech, Genomictree, HTG Molecular Diagnostics, Luminex, MolecularMD, IntegraGen, LabCorp diagnostics, Myriad, Natera, PacBio, Pathway Genomics, Qiagen, and Roche Diagnostic.
CHAPTER 1. Industry Overview of Genetic Testing Market
1.1. Definition and Scope
1.1.1. Definition of Genetic Testing
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Genetic Testing Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Genetic Testing Market By Type
1.2.3. Genetic Testing Market By Product
1.2.4. Genetic Testing Market By Technology
1.2.5. Genetic Testing Market By Application
1.2.6. Genetic Testing Market By End-user
1.2.7. Genetic Testing Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Genetic Testing Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Genetic Testing Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Genetic Testing Market By Type
5.1. Introduction
5.2. Genetic Testing Revenue By Type
5.2.1. Genetic Testing Revenue (USD Billion) and Forecast, By Type, 2020-2032
5.2.2. Predictive Testing
5.2.2.1. Predictive Testing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Prenatal & Newborn Testing
5.2.3.1. Prenatal & Newborn Testing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Diagnostic Testing
5.2.4.1. Diagnostic Testing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.5. Carrier Testing
5.2.5.1. Carrier Testing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.6. Pharmacogenomic Testing
5.2.6.1. Pharmacogenomic Testing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.7. Others
5.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Genetic Testing Market By Product
6.1. Introduction
6.2. Genetic Testing Revenue By Product
6.2.1. Genetic Testing Revenue (USD Billion) and Forecast, By Product, 2020-2032
6.2.2. Consumables
6.2.2.1. Consumables Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Equipment
6.2.3.1. Equipment Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Software & Services
6.2.4.1. Software & Services Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Genetic Testing Market By Technology
7.1. Introduction
7.2. Genetic Testing Revenue By Technology
7.2.1. Genetic Testing Revenue (USD Billion) and Forecast, By Technology, 2020-2032
7.2.2. Biochemical Testing
7.2.2.1. Biochemical Testing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Cytogenetic Testing/ Chromosome Analysis
7.2.3.1. Cytogenetic Testing/ Chromosome Analysis Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Molecular Testing
7.2.4.1. Molecular Testing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4.2. DNA Sequencing
7.2.4.2.1. DNA Sequencing Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4.3. Others
7.2.4.3.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Genetic Testing Market By Application
8.1. Introduction
8.2. Genetic Testing Revenue By Application
8.2.1. Genetic Testing Revenue (USD Billion) and Forecast, By Application, 2020-2032
8.2.2. Ancestry & Ethnicity
8.2.2.1. Ancestry & Ethnicity Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Traits Screening
8.2.3.1. Traits Screening Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Genetic Disease Carrier Status
8.2.4.1. Genetic Disease Carrier Status Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.5. New Baby Screening
8.2.5.1. New Baby Screening Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.6. Health and Wellness-Predisposition/Risk/Tendency
8.2.6.1. Health and Wellness-Predisposition/Risk/Tendency Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Genetic Testing Market By Country
9.1. North America Genetic Testing Market Overview
9.2. U.S.
9.2.1. U.S. Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
9.2.2. U.S. Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
9.2.3. U.S. Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
9.2.4. U.S. Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
9.2.5. U.S. Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
9.3. Canada
9.3.1. Canada Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
9.3.2. Canada Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
9.3.3. Canada Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
9.3.4. Canada Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
9.3.5. Canada Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Genetic Testing Market By Country
10.1. Europe Genetic Testing Market Overview
10.2. U.K.
10.2.1. U.K. Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
10.2.2. U.K. Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
10.2.3. U.K. Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
10.2.4. U.K. Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
10.2.5. U.K. Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.3. Germany
10.3.1. Germany Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
10.3.2. Germany Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
10.3.3. Germany Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
10.3.4. Germany Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
10.3.5. Germany Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.4. France
10.4.1. France Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
10.4.2. France Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
10.4.3. France Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
10.4.4. France Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
10.4.5. France Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.5. Spain
10.5.1. Spain Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
10.5.2. Spain Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
10.5.3. Spain Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
10.5.4. Spain Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
10.5.5. Spain Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
10.6.2. Rest of Europe Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
10.6.3. Rest of Europe Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
10.6.4. Rest of Europe Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
10.6.5. Rest of Europe Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Genetic Testing Market By Country
11.1. Asia Pacific Genetic Testing Market Overview
11.2. China
11.2.1. China Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
11.2.2. China Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
11.2.3. China Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.2.4. China Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
11.2.5. China Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
11.3. Japan
11.3.1. Japan Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
11.3.2. Japan Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
11.3.3. Japan Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.3.4. Japan Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
11.3.5. Japan Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
11.4. India
11.4.1. India Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
11.4.2. India Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
11.4.3. India Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.4.4. India Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
11.4.5. India Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
11.5. Australia
11.5.1. Australia Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
11.5.2. Australia Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
11.5.3. Australia Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.5.4. Australia Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
11.5.5. Australia Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
11.6. South Korea
11.6.1. South Korea Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
11.6.2. South Korea Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
11.6.3. South Korea Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.6.4. South Korea Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
11.6.5. South Korea Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
11.7.2. Rest of Asia-Pacific Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
11.7.3. Rest of Asia-Pacific Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
11.7.4. Rest of Asia-Pacific Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
11.7.5. Rest of Asia-Pacific Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Genetic Testing Market By Country
12.1. Latin America Genetic Testing Market Overview
12.2. Brazil
12.2.1. Brazil Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
12.2.2. Brazil Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
12.2.3. Brazil Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
12.2.4. Brazil Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
12.2.5. Brazil Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
12.3. Mexico
12.3.1. Mexico Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
12.3.2. Mexico Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
12.3.3. Mexico Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
12.3.4. Mexico Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
12.3.5. Mexico Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
12.4.2. Rest of Latin America Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
12.4.3. Rest of Latin America Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
12.4.4. Rest of Latin America Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
12.4.5. Rest of Latin America Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Genetic Testing Market By Country
13.1. Middle East & Africa Genetic Testing Market Overview
13.2. GCC
13.2.1. GCC Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
13.2.2. GCC Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
13.2.3. GCC Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
13.2.4. GCC Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
13.2.5. GCC Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
13.3. South Africa
13.3.1. South Africa Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
13.3.2. South Africa Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
13.3.3. South Africa Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
13.3.4. South Africa Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
13.3.5. South Africa Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Genetic Testing Revenue (USD Billion) and Forecast By Type, 2020-2032
13.4.2. Rest of Middle East & Africa Genetic Testing Revenue (USD Billion) and Forecast By Product, 2020-2032
13.4.3. Rest of Middle East & Africa Genetic Testing Revenue (USD Billion) and Forecast By Technology, 2020-2032
13.4.4. Rest of Middle East & Africa Genetic Testing Revenue (USD Billion) and Forecast By Application, 2020-2032
13.4.5. Rest of Middle East & Africa Genetic Testing Revenue (USD Billion) and Forecast By End-user, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Genetic Testing Market
14.1. Genetic Testing Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Genetic Testing Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. 23andMe
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. 23andMe 2022 Genetic Testing Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Abbott Molecular
15.3. Biocartis
15.4. BioHelix
15.5. Bayer Diagnostics
15.6. BioMerieux
15.7. BGI
15.8. Celera Genomics
15.9. Cepheid
15.10. Counsyl
15.11. deCODEme
15.12. Genentech
15.13. Genomictree
15.14. HTG Molecular Diagnostics
15.15. Luminex
15.16. MolecularMD
15.17. IntegraGen
15.18. LabCorp diagnostics
15.19. Myriad
15.20. Natera
15.21. PacBio
15.22. Pathway Genomics
15.23. Qiagen
15.24. Roche Diagnostic
